Tailoring nanoparticle designs to target cancer based on tumor pathophysiology

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 9, 2016, Pages E1142-E1151

  Sykes, Edward A ^a   Dai, Qin ^a   Sarsons, Christopher D ^b   Chen, Juan ^c   Rocheleau, Jonathan V ^a,d   Hwang, David M ^e   Zheng, Gang ^c   Cramb, David T ^b   Rinker, Kristina D ^b   Chan, Warren C W ^a,c,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancer; Nano bio interactions; Nanoparticles; Targeting; Tumor

Indexed keywords

COLLAGEN; COLLAGEN GEL; GOLD NANOPARTICLE; NANOPARTICLE; GOLD; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; HUMAN; HUMAN CELL; MALE; MONTE CARLO METHOD; MOUSE; NANOTECHNOLOGY; NEOPLASM; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TUMOR VOLUME; ANIMAL; BREAST NEOPLASMS; CHEMISTRY; FEMALE; NUDE MOUSE; PATHOPHYSIOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GOLD; HETEROGRAFTS; HUMANS; MALE; METAL NANOPARTICLES; MICE; MICE, NUDE; MONTE CARLO METHOD; PROSTATIC NEOPLASMS;

EID: 84959421064     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1521265113     Document Type: Article

References (42)

1. Chou LYT, Zagorovsky K, Chan WCW (2014) DNA assembly of nanoparticle superstructures for controlled biological delivery and elimination. Nat Nanotechnol 9(2):148-155.
2. He X, Wang K, Cheng Z (2010) In vivo near-infrared fluorescence imaging of cancer with nanoparticle-based probes. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2(4):349-366.
3. Nam T, et al. (2010) Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging. Bioconjug Chem 21(4):578-582.
4. Yang J, et al. (2007) Multifunctional magneto-polymeric nanohybrids for targeted detection and synergistic therapeutic effects on breast cancer. Angew Chem Int Ed Engl 46(46):8836-8839.
5. Cherukuri P, Glazer ES, Curley SA (2010) Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev 62(3):339-345.
6. Bae YH, Park K (2011) Targeted drug delivery to tumors: Myths, reality and possibility. J Control Release 153(3):198-205.
7. Sykes EA, Dai Q, Tsoi KM, Hwang DM, Chan WCW (2014) Nanoparticle exposure in animals can be visualized in the skin and analysed via skin biopsy. Nat Commun 5:3796.
8. De Jong WH, et al. (2008) Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29(12):1912-1919.
9. Cole AJ, David AE, Wang J, Galbán CJ, Yang VC (2011) Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials 32(26):6291-6301.
10. Kumar R, et al. (2010) In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 4(2):699-708.
11. Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 53(2):283-318.
12. Yaehne K, et al. (2013) Nanoparticle accumulation in angiogenic tissues: Towards predictable pharmacokinetics. Small 9(18):3118-3127.
13. Huang X, Teng X, Chen D, Tang F, He J (2010) The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 31(3):438-448.
14. Hauck TS, Ghazani AA, Chan WCW (2008) Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 4(1): 153-159.
15. Treuel L, Jiang X, Nienhaus GU (2013) New views on cellular uptake and trafficking of manufactured nanoparticles. J R Soc Interface 10(82):20120939.
16. Brown JM, Giaccia AJ (1998) The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy. Cancer Res 58(7):1408-1416.
17. Junttila MR, de Sauvage FJ (2013) Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 501(7467):346-354.
18. Rosenblum D, Peer D (2014) Omics-based nanomedicine: The future of personalized oncology. Cancer Lett 352(1):126-136.
19. McMillin DW, Negri JM, Mitsiades CS (2013) The role of tumour-stromal interactions in modifying drug response: Challenges and opportunities. Nat Rev Drug Discov 12(3): 217-228.
20. Thurber GM, Schmidt MM, Wittrup KD (2008) Factors determining antibody distribution in tumors. Trends Pharmacol Sci 29(2):57-61.
21. Stylianopoulos T, et al. (2010) Diffusion of particles in the extracellular matrix: The effect of repulsive electrostatic interactions. Biophys J 99(5):1342-1349.
22. Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: A dynamic niche in cancer progression. J Cell Biol 196(4):395-406.
23. Rich L, Whittaker P (2005) Collagen and picrosirius red staining: A polarized light assessment of fibrillar hue and spatial distribution. Braz J Morphol Sci 22:97-104.
24. Chen X, Nadiarynkh O, Plotnikov S, Campagnola PJ (2012) Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure. Nat Protoc 7(4):654-669.
25. Brown E, et al. (2003) Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med 9(6):796-800.
26. Sykes EA, Chen J, Zheng G, Chan WCW (2014) Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano 8(6):5696-5706.
27. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WCW (2009) Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 9(5):1909-1915.
28. Perrault SD, Chan WCW (2009) Synthesis and surface modification of highly monodispersed, spherical gold nanoparticles of 50-200 nm. J Am Chem Soc 131(47):17042-17043.
29. Chou LYT, Chan WCW (2012) Fluorescence-tagged gold nanoparticles for rapidly characterizing the size-dependent biodistribution in tumor models. Adv Healthc Mater 1(6):714-721.
30. Provenzano PP, et al. (2008) Collagen density promotes mammary tumor initiation and progression. BMC Med 6(1):11.
31. Dudley DT, et al. (2014) A 3D matrix platform for the rapid generation of therapeutic anti-human carcinoma monoclonal antibodies. Proc Natl Acad Sci USA 111(41):14882-14887.
32. Stylianopoulos T, Diop-Frimpong B, Munn LL, Jain RK (2010) Diffusion anisotropy in collagen gels and tumors: The effect of fiber network orientation. Biophys J 99(10):3119-3128.
33. Jakobsen I, Lyng H, Kaalhus O, Rofstad EK (1995) MRI of human tumor xenografts in vivo: Proton relaxation times and extracellular tumor volume. Magn Reson Imaging 13(5):693-700.
34. Krol A, Maresca J, Dewhirst MW, Yuan F (1999) Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: Implications for drug delivery. Cancer Res 59(16):4136-4141.
35. Walkey CD, Olsen JB, Guo H, Emili A, Chan WCW (2012) Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134(4):2139-2147.
36. Varin A, Mukhopadhyay S, Herbein G, Gordon S (2010) Alternative activation of macrophages by IL-4 impairs phagocytosis of pathogens but potentiates microbial-induced signalling and cytokine secretion. Blood 115(2):353-362.
37. Wang B, et al. (2011) Transition of tumor-associated macrophages from MHC class II(hi) to MHC class II(low) mediates tumor progression in mice. BMC Immunol 12(1):43.
38. Albanese A, Tang PS, Chan WCW (2012) The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 14:1-16.
39. Dawidczyk CM, Russell LM, Searson PC (2014) Nanomedicines for cancer therapy: State-of-the-art and limitations to pre-clinical studies that hinder future developments. Front Chem 2:69.
40. Josefsson A, et al. (2005) Tumor size, vascular density and proliferation as prognostic markers in GS 6 and GS 7 prostate tumors in patients with long follow-up and noncurative treatment. Eur Urol 48(4):577-583.
41. Wisnivesky JP, Yankelevitz D, Henschke CI (2004) The effect of tumor size on curability of stage I non-small cell lung cancers. Chest 126(3):761-765.
42. Yu K-D, et al. (2012) Effect of large tumor size on cancer-specific mortality in node-negative breast cancer. Mayo Clin Proc 87(12):1171-1180.